Sanofi, GSK Start Final Testing Phase Of COVID-19 Vaccine
May 27, 2021 at 10:00 AM EDT
Sanofi SA and GlaxoSmithKline plc have launched a Phase 3 trial for its recombinant COVID-19 vaccine candidate, which they hope to get approved by the end of 2021.